These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8299548)

  • 1. [Impact of personality factors in depression].
    Quitkin FM
    Encephale; 1993 Aug; 19 Spec No 3():491-2. PubMed ID: 8299548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
    Parsons B; Quitkin FM; McGrath PJ; Stewart JW; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin JG; Wager SG; Nunes E
    Psychopharmacol Bull; 1989; 25(4):524-34. PubMed ID: 2698483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The depressed borderline: one disorder or two?
    Soloff PH; Cornelius J; George A
    Psychopharmacol Bull; 1991; 27(1):23-30. PubMed ID: 1862202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol vs. phenelzine in continuation therapy of borderline disorder.
    Cornelius JR; Soloff PH; George A; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1993; 29(2):333-7. PubMed ID: 8290683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
    McGrath PJ; Stewart JW; Harrison WM; Ocepek-Welikson K; Rabkin JG; Nunes EN; Wager SG; Tricamo E; Quitkin FM; Klein DF
    J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
    Mercier MA; Stewart JW; Quitkin FM
    J Clin Psychiatry; 1992 May; 53(5):166-70. PubMed ID: 1592844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression.
    Smith DJ; Muir WJ; Blackwood DH
    J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic approach to the classification and pharmacotherapy of nonpsychotic major depression and dysthymia.
    Osser DN
    J Clin Psychopharmacol; 1993 Apr; 13(2):133-44. PubMed ID: 8463446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline personality disorder and depression.
    Liebowitz MR
    Am J Psychiatry; 1992 Apr; 149(4):581. PubMed ID: 1554061
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining the boundaries of atypical depression.
    Quitkin FM; Harrison W; Liebowitz M; McGrath P; Rabkin JG; Stewart J; Markowitz J
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):19-21. PubMed ID: 6376482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathologic personality, temperament and treatment].
    Akiskal HS
    Encephale; 1995 Mar; 21 Spec No 2():47-9. PubMed ID: 7588180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating DSM-IV depression with atypical features.
    Stewart JW; Thase ME
    J Clin Psychiatry; 2007 Apr; 68(4):e10. PubMed ID: 17474800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship of hysteroid dysphoria and borderline personality disorder.
    Liebowitz MR; Klein DF
    Psychiatr Clin North Am; 1981 Apr; 4(1):67-87. PubMed ID: 7232238
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical depression.
    Silberman EK; Sullivan JL
    Psychiatr Clin North Am; 1984 Sep; 7(3):535-47. PubMed ID: 6384959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A history of the concept of atypical depression.
    Davidson JR
    J Clin Psychiatry; 2007; 68 Suppl 3():10-5. PubMed ID: 17348762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.